SPI Healthcare
3 597,97
|
5,14
|
0,14 %
|
Analysen zu SPI Healthcare-Werten
12.03.24 | Roche Equal Weight | Barclays Capital | |
26.02.24 | Roche Hold | Jefferies & Company Inc. | |
22.02.24 | Roche Neutral | UBS AG | |
21.02.24 | Roche Underweight | JP Morgan Chase & Co. | |
20.02.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.02.24 | Novartis Buy | Deutsche Bank AG | |
07.02.24 | Novartis Neutral | JP Morgan Chase & Co. | |
06.02.24 | Novartis Underweight | Barclays Capital | |
06.02.24 | Novartis Buy | UBS AG | |
05.02.24 | Roche Sell | Deutsche Bank AG | |
05.02.24 | Novartis Buy | Jefferies & Company Inc. | |
05.02.24 | Roche Neutral | UBS AG | |
02.02.24 | Roche Kaufen | DZ BANK | |
02.02.24 | Roche Equal Weight | Barclays Capital | |
02.02.24 | Roche Sell | Deutsche Bank AG | |
02.02.24 | Novartis Buy | Deutsche Bank AG | |
01.02.24 | Roche Neutral | UBS AG | |
01.02.24 | Roche Underweight | JP Morgan Chase & Co. | |
01.02.24 | Roche Hold | Jefferies & Company Inc. | |
31.01.24 | Novartis Kaufen | DZ BANK | |
31.01.24 | Novartis Buy | UBS AG | |
31.01.24 | Novartis Buy | Jefferies & Company Inc. | |
30.01.24 | Roche Neutral | UBS AG | |
30.01.24 | Novartis Buy | UBS AG | |
30.01.24 | Roche Sell | Deutsche Bank AG | |
22.01.24 | Roche Hold | Deutsche Bank AG | |
19.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
16.01.24 | Novartis Buy | Jefferies & Company Inc. | |
16.01.24 | Roche Hold | Jefferies & Company Inc. | |
15.01.24 | Roche Neutral | UBS AG | |
15.01.24 | Novartis Buy | UBS AG | |
15.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
11.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
09.01.24 | Roche Equal Weight | Barclays Capital | |
09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
08.01.24 | Novartis Neutral | UBS AG | |
05.01.24 | Novartis Buy | Deutsche Bank AG | |
03.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
03.01.24 | Novartis Buy | Jefferies & Company Inc. |